glp 1 elderly GLP-1-derived therapies and sarcopenia: plea for a specific focus on at risk special populations Are weight-loss drugs safe for

However, researchers noted several limitations, including the single-centre, retrospective design, reliance on chart abstraction rather than validated disease activity indices, and the possibility of residual confounding

Mitochondrial dysfunction leads to cortical under-connectivity and cognitive impairment

Prescriptions of GLP-1RA have surged by 300% from 2020 to 2022, reaching 9 million annually [10], reflecting the high prevalence of T2D (15%) and obesity (42%) among U.S

[DOI] [PMC free article] [PubMed] [Google Scholar] 74.Currais A, Farrokhi C, Dargusch R, Goujon-Svrzic M, Maher P

There is also a risk of more serious side effects, including pancreatitis, gallbladder problems, and changes in vision